Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P A Cleary

Showing results (21-30 of 34) with videos related to

Pageof 4
Sort By:
Diabetologia|August 31, 2010
Biomedical risk factors for decreased cognitive functioning in type 1 diabetes: an 18 year follow-up of the Diabetes Control and Complications Trial (DCCT) cohortA M Jacobson, C M Ryan, P A Cleary, et al.
Gastroenterology|April 1, 1982
National Cooperative Gallstone Study: the effect of chenodeoxycholic acid on lipoproteins and apolipoproteinsJ J Albers, S M Grundy, P A Cleary, et al.
Diabetes|October 1, 1995
Levels of lipoprotein(a), apolipoprotein B, and lipoprotein cholesterol distribution in IDDM. Results from follow-up in the Diabetes Control and Complications TrialJ Q Purnell, S M Marcovina, J E Hokanson, et al.
Diabetes Care|July 2, 1999
Increased small dense LDL and intermediate-density lipoprotein with albuminuria in type 1 diabetesS D Sibley, J E Hokanson, M W Steffes, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|March 16, 2012
Use of the Michigan Neuropathy Screening Instrument as a measure of distal symmetrical peripheral neuropathy in Type 1 diabetes: results from the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and ComplicationsW H Herman, R Pop-Busui, B H Braffett, et al.
Diabetes|April 2, 1999
Skin collagen glycation, glycoxidation, and crosslinking are lower in subjects with long-term intensive versus conventional therapy of type 1 diabetes: relevance of glycated collagen products versus HbA1c as markers of diabetic complications. DCCT Skin Collagen Ancillary Study Group. Diabetes Control and Complications TrialV M Monnier, O Bautista, D Kenny, et al.
The New England Journal of Medicine|December 9, 1993
The effect of corticosteroids for acute optic neuritis on the subsequent development of multiple sclerosis. The Optic Neuritis Study GroupR W Beck, P A Cleary, J D Trobe, et al.
Contraception|August 1, 1986
Progestins and oral contraceptive-induced lipoprotein changes: a prospective studyA Lipson, D B Stoy, J C LaRosa, et al.
Journal of Biological Response Modifiers|April 1, 1985
A randomized trial to evaluate the immunorestorative properties of synthetic thymosin-alpha 1 in patients with lung cancerR S Schulof, M J Lloyd, P A Cleary, et al.
International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity|December 1, 1994
The use of bioelectrical impedance analysis (BIA) to estimate body composition in the Diabetes Control and Complications Trial (DCCT)L A Leiter, H C Lukaski, D J Kenny, et al.
Pageof 4

Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
Diabetologia|August 31, 2010
Biomedical risk factors for decreased cognitive functioning in type 1 diabetes: an 18 year follow-up of the Diabetes Control and Complications Trial (DCCT) cohortA M Jacobson, C M Ryan, P A Cleary, et al.
Gastroenterology|April 1, 1982
National Cooperative Gallstone Study: the effect of chenodeoxycholic acid on lipoproteins and apolipoproteinsJ J Albers, S M Grundy, P A Cleary, et al.
Diabetes|October 1, 1995
Levels of lipoprotein(a), apolipoprotein B, and lipoprotein cholesterol distribution in IDDM. Results from follow-up in the Diabetes Control and Complications TrialJ Q Purnell, S M Marcovina, J E Hokanson, et al.
Diabetes Care|July 2, 1999
Increased small dense LDL and intermediate-density lipoprotein with albuminuria in type 1 diabetesS D Sibley, J E Hokanson, M W Steffes, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|March 16, 2012
Use of the Michigan Neuropathy Screening Instrument as a measure of distal symmetrical peripheral neuropathy in Type 1 diabetes: results from the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and ComplicationsW H Herman, R Pop-Busui, B H Braffett, et al.
Diabetes|April 2, 1999
Skin collagen glycation, glycoxidation, and crosslinking are lower in subjects with long-term intensive versus conventional therapy of type 1 diabetes: relevance of glycated collagen products versus HbA1c as markers of diabetic complications. DCCT Skin Collagen Ancillary Study Group. Diabetes Control and Complications TrialV M Monnier, O Bautista, D Kenny, et al.
The New England Journal of Medicine|December 9, 1993
The effect of corticosteroids for acute optic neuritis on the subsequent development of multiple sclerosis. The Optic Neuritis Study GroupR W Beck, P A Cleary, J D Trobe, et al.
Contraception|August 1, 1986
Progestins and oral contraceptive-induced lipoprotein changes: a prospective studyA Lipson, D B Stoy, J C LaRosa, et al.
Journal of Biological Response Modifiers|April 1, 1985
A randomized trial to evaluate the immunorestorative properties of synthetic thymosin-alpha 1 in patients with lung cancerR S Schulof, M J Lloyd, P A Cleary, et al.
International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity|December 1, 1994
The use of bioelectrical impedance analysis (BIA) to estimate body composition in the Diabetes Control and Complications Trial (DCCT)L A Leiter, H C Lukaski, D J Kenny, et al.
Pageof 4